> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# American Health Packaging Recall of Valsartan
- URL: https://www.fdaweb.com/american-health-packaging-recall-of-valsartan/
- Published: 2019-03-08T12:00:00.000Z
- Updated: 2026-09-15T01:11:03.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143564

American Health Packaging has recalled one lot of valsartan tablets,160 mg , due to the detection of trace amounts of an unexpected carcinogen in the finished drug product. The impurity is N-Nitrosodiethylamine, which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, a [recall notice](https://www.fda.gov/Safety/Recalls/ucm632924.htm?ref=fdaweb.com) says. The recall is being initiated in response to a previous recall by the manufacturer (Aurobindo Pharma USA), which included the affected lot repackaged by American Health Packaging. Valsartan is indicated to control high blood pressure and for the treatment of heart failure.